Department of Hepatobiliary Surgery, Xijing Hospital, The Fourth Military Medical University, Xi'an, Shannxi, People's Republic of China.
Cancer Lett. 2010 Sep 28;295(2):198-204. doi: 10.1016/j.canlet.2010.03.001. Epub 2010 Mar 24.
Na(+)/H(+) exchanger 1 (NHE1) plays a significant role in tumor metastasis. However, the exact mechanisms by which NHE1 mediates cell invasion and migration, especially in hepatocellular carcinoma (HCC), are not yet known. In the current study, we show for the first time that the inhibition of NHE1 by 5-(N-ethyl-N-isopropyl) amiloride (EIPA) is able to suppress migration and invasion of HepG2 cells under hypoxic conditions. In addition, hypoxia activated ERK1/2, which in turn promoted the production of MMP-2, MMP-9 and VEGF. EIPA's suppressive role was determined to act through down-regulation of MMP-2, MMP-9 and VEGF in an ERK1/2 dependent manner. The data demonstrate that NHE1 plays a role in HCC invasion and that NHE1 may be a potential therapeutic target for HCC treatment.
钠/氢交换器 1(NHE1)在肿瘤转移中起重要作用。然而,NHE1 介导细胞侵袭和迁移的确切机制,特别是在肝细胞癌(HCC)中,尚不清楚。在本研究中,我们首次表明,5-(N-乙基-N-异丙基)阿米洛利(EIPA)抑制 NHE1 能够抑制低氧条件下 HepG2 细胞的迁移和侵袭。此外,缺氧激活了 ERK1/2,进而促进了 MMP-2、MMP-9 和 VEGF 的产生。EIPA 的抑制作用通过 ERK1/2 依赖性方式下调 MMP-2、MMP-9 和 VEGF 来实现。数据表明,NHE1 在 HCC 侵袭中起作用,NHE1 可能是 HCC 治疗的潜在治疗靶点。